Crozet BioPharma Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Crozet BioPharma's estimated annual revenue is currently $1.7M per year.(i)
  • Crozet BioPharma's estimated revenue per employee is $155,000

Employee Data

  • Crozet BioPharma has 11 Employees.(i)
  • Crozet BioPharma grew their employee count by -8% last year.

Crozet BioPharma's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Crozet BioPharma?

Accelerating development of biological products that prevent or treat important human diseases. Our founding principle is to have a lasting, positive impact on people's health and lives. We take pride in putting our knowledge and expertise to work for this cause every day. • Multi-disciplinary team of development professionals with 10 successful product launches in the infectious disease space • Most recently engaged in advancing the first successful Ebola vaccine towards licensure • Focused on accelerating development of biological products against infectious diseases and cancer • We offer companies an alternative to hiring or diverting costly personnel to the development of a pipeline product by providing an external development team • This approach allows corporations flexible use of their resources, minimizes capital investment, and enhances return on investment • Crozet’s customers include public and private biopharmaceutical companies and non-profit organizations

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M11-8%N/A
#2
$1M1110%N/A
#3
$1.7M1110%N/A
#4
$1M11N/AN/A
#5
$3M12-8%N/A